# Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

> **NCT00038870** · NA · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Acute Myelogenous Leukemia
- Chronic Myelogenous Leukemia

## Interventions

- **BIOLOGICAL:** Dendritic Cell Activated Lymphocyte

## Key facts

- **NCT ID:** NCT00038870
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2001-01-31
- **Primary completion:** 2003-01-14
- **Final completion:** 2003-01-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Slow accrual.
- **Last updated:** 2018-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00038870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00038870, "Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00038870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*